Literature DB >> 27240453

Myeloid derived suppressor cells and autoimmunity.

Peter Boros1, Jordi Ochando2, Margit Zeher3.   

Abstract

Myeloid-derived suppressor cells are a heterogeneous group of immature myeloid cells with immunoregulatory function. When activated and expanded, these cells can suppress T cell functions via cell-to cell interactions as well as soluble mediators. Recent studies investigated the involvement of MDSC in autoimmune diseases. Some papers have described beneficial effect of MDSC during the course of autoimmune diseases, and suggest a potential role as a treatment option, while others failed to detect these effects. Their contributions to autoimmune diseases are not fully understood, and many questions and some controversies remain as to the expansion, activation, and inhibitory functions of MDSC. This review aims to summarize current knowledge of MDSC in autoimmune disorders.
Copyright © 2016 American Society for Histocompatibility and Immunogenetics. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Inflammatory bowel disease; Myeloid derived suppressor cells; Rheumatoid arthritis; SLE; Type 1 diabetes

Mesh:

Year:  2016        PMID: 27240453     DOI: 10.1016/j.humimm.2016.05.024

Source DB:  PubMed          Journal:  Hum Immunol        ISSN: 0198-8859            Impact factor:   2.850


  36 in total

1.  Open-Label Clinical Trials of Oral Pulse Dexamethasone for Adults with Idiopathic Nephrotic Syndrome.

Authors:  Monique E Cho; Mary H Branton; David A Smith; Linda Bartlett; Lilian Howard; James C Reynolds; Donald Rosenstein; Sanjeev Sethi; M Berenice Nava; Laura Barisoni; Fernando C Fervenza; Jeffrey B Kopp
Journal:  Am J Nephrol       Date:  2019-04-09       Impact factor: 3.754

2.  Immunomodulatory nanoparticles ameliorate disease in the Leishmania (Viannia) panamensis mouse model.

Authors:  Alyssa L Siefert; Allison Ehrlich; María Jesús Corral; Karen Goldsmith-Pestana; Diane McMahon-Pratt; Tarek M Fahmy
Journal:  Biomaterials       Date:  2016-09-06       Impact factor: 12.479

Review 3.  Recent advances in myeloid-derived suppressor cell biology.

Authors:  Mahmoud Mohammad Yaseen; Nizar Mohammad Abuharfeil; Homa Darmani; Ammar Daoud
Journal:  Front Med       Date:  2020-09-02       Impact factor: 4.592

4.  Mesenchymal stem cell transplantation alleviated atherosclerosis in systemic lupus erythematosus through reducing MDSCs.

Authors:  Genhong Yao; Jingjing Qi; Xiaojing Li; Xiaojun Tang; Wenchao Li; Weiwei Chen; Nan Xia; Shiying Wang; Lingyun Sun
Journal:  Stem Cell Res Ther       Date:  2022-07-18       Impact factor: 8.079

Review 5.  Myeloid derived-suppressor cells: their role in cancer and obesity.

Authors:  Suzanne Ostrand-Rosenberg
Journal:  Curr Opin Immunol       Date:  2018-03-13       Impact factor: 7.486

Review 6.  Internal Affairs: Tenascin-C as a Clinically Relevant, Endogenous Driver of Innate Immunity.

Authors:  Anna M Marzeda; Kim S Midwood
Journal:  J Histochem Cytochem       Date:  2018-01-31       Impact factor: 2.479

Review 7.  Role of Myeloid-derived suppressor cell (MDSC) in autoimmunity and its potential as a therapeutic target.

Authors:  Ehsan Nourbakhsh; Ali Mohammadi; Mohammad Salemizadeh Parizi; Atena Mansouri; Farnoosh Ebrahimzadeh
Journal:  Inflammopharmacology       Date:  2021-07-20       Impact factor: 4.473

8.  Comparing thermal stress reduction strategies that influence MDSC accumulation in tumor bearing mice.

Authors:  Cameron MacDonald; Samuel Ministero; Manu Pandey; Denisha Robinson; Evan Forti Hong; Bonnie Hylander; Philip McCarthy; Christopher Gordon; Elizabeth Repasky; Hemn Mohammadpour
Journal:  Cell Immunol       Date:  2021-01-09       Impact factor: 4.178

9.  Linking erythropoietin to Treg-dependent allograft survival through myeloid cells.

Authors:  Julian K Horwitz; Sofia Bin; Robert L Fairchild; Karen S Keslar; Zhengzi Yi; Weijia Zhang; Vasile I Pavlov; Yansui Li; Joren C Madsen; Paolo Cravedi; Peter S Heeger
Journal:  JCI Insight       Date:  2022-05-23

Review 10.  Regulatory B cells in cancer.

Authors:  Daniel Michaud; Colleen R Steward; Bhalchandra Mirlekar; Yuliya Pylayeva-Gupta
Journal:  Immunol Rev       Date:  2020-12-23       Impact factor: 12.988

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.